4//SEC Filing
Li Dean Y 4
Accession 0001601830-24-000069
CIK 0001601830other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:11 PM ET
Size
9.4 KB
Accession
0001601830-24-000069
Insider Transaction Report
Form 4
Li Dean Y
Director
Transactions
- Award
Class A Common Stock
2024-06-03+13,097→ 72,186 total - Award
Stock Option (Right to Buy)
2024-06-03+26,193→ 26,193 totalExercise: $8.59Exp: 2034-06-03→ Class A Common Stock (26,193 underlying)
Holdings
- 1,422,048(indirect: By Trust)
Class A Common Stock
- 1,269,796(indirect: By Dean Y. Li GRAT)
Class A Common Stock
- 421,000(indirect: By Trust)
Class A Common Stock
Footnotes (2)
- [F1]Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 3, 2025 or the day prior to the Issuer's 2025 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer.
- [F2]The shares subject to this option will vest and become exercisable on the earlier of June 3, 2025 or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001837016
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:11 PM ET
- Size
- 9.4 KB